Braemar Introduces the DL900 Advanced Holter Monitor

Saturday, May 31, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

MINNEAPOLIS, May 30 Braemar, Inc., a subsidiaryof Biotel, Inc. (OTC Bulletin Board: BTEL) and a world leader in ambulatorycardiac monitoring devices, has introduced the DL900, an advanced digitalHolter monitor. At 1.75 ounces, the new monitor is more compact and discretethan earlier models, yet provides a large liquid crystal display (LCD) andextended recording time of up to seven days. A newly designed, custom analogIC for signal acquisition is the technology platform for the advancedcapabilities of the DL900. The device was showcased at the recent AmericanCollege of Cardiologists (ACC) conference in Chicago and the Heart RhythmSociety (HRS) conference in San Francisco.

"The DL900 was enthusiastically received at both ACC and HRS," HarryStrandquist, President and CEO of Braemar, Inc. commented. "Our partners arein the process of integrating this new device into their ambulatory cardiacmonitoring product lines."

The DL900 increases diagnostic yield and provides extended recording timeof several days or more for clinical research applications. The devicecombines high speed USB transfer capability with the ability to use aremovable SD memory card. The DL900 provides high-resolution recordings aswell as high sampling rate options suitable for both clinical and researchapplications. A programmable pacemaker detection capability provides theclinician with additional data.

The DL900's advanced technology platform has the capacity to supportnumerous OEM capabilities, including multi parameter recording and datastorage of a variety of physiological signals.

For photo, go to http://www.biotelinc.com/images/BraemarDL900.jpg.

Braemar, Inc., designs, develops, engineers and manufactures ambulatorycardiac monitoring and other medical devices. The company provides high-quality, reliable devices to OEM partners worldwide.

SOURCE Biotel, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store